Diabetic Patients With End-Stage Renal Disease
NCT00435786 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2007-02-15
Summary
In diabetic patients with end-stage renal disease to investigate the prevalence of diabetic complications and quality of life and to compare with non-diabetic patients with ESRD and diabetic patients with normal kidney function.
Conditions
- Diabetes
- End-Stage Renal Disease
- Cardiovascular Diseases
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Vibeke R Sørensen, MD · Department of Nephrology, Rigshospitalet
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Molecular Analysis of Diabetic Kidney Disease Biopsies
NCT04029402 ·Status: RECRUITING
-
May Metformin be Used in Renal Failure?
NCT02710448 ·Status: COMPLETED ·Phase: PHASE2
-
PeRsOnalising Treatment Of Diabetic Nephropathy:
NCT03509454 ·Status: COMPLETED
-
Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This
NCT02042768 ·Status: COMPLETED
-
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01551446 ·Status: WITHDRAWN ·Phase: PHASE1
-
Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes
NCT02580266 ·Status: WITHDRAWN
-
TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
NCT00905528 ·Status: COMPLETED
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
NCT01835678 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
NCT02895750 ·Status: COMPLETED ·Phase: PHASE2
-
Nitric Oxide (NO) Activity and Diabetic Nephropathy
NCT00136188 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT05004428 ·Status: COMPLETED
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302 ·Status: RECRUITING ·Phase: PHASE3
-
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
NCT06101901 ·Status: NOT_YET_RECRUITING
-
SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data
NCT06769646 ·Status: COMPLETED
-
Metformin in Kidney Disease
NCT02252081 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
NCT05373004 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
NCT03859817 ·Status: UNKNOWN
-
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
NCT00253786 ·Status: COMPLETED ·Phase: NA
-
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
NCT05857085 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Prediabetes in End Stage Renal Disease on Dialysis
NCT07337083 ·Status: COMPLETED
-
Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
NCT02981966 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease
NCT05465317 ·Status: COMPLETED